- Report
- August 2026
- 160 Pages
Global
From €3061EUR$3,320USD£2,555GBP
€3826EUR$4,150USD£3,194GBP
- Report
- August 2026
- 160 Pages
Global
From €3061EUR$3,320USD£2,555GBP
€3826EUR$4,150USD£3,194GBP
- Report
- August 2026
- 160 Pages
Global
From €3061EUR$3,320USD£2,555GBP
€3826EUR$4,150USD£3,194GBP
- Report
- March 2026
- 140 Pages
Global
From €4471EUR$4,850USD£3,733GBP
- Report
- July 2026
- 150 Pages
Global
From €4471EUR$4,850USD£3,733GBP
- Report
- March 2026
- 191 Pages
Global
From €4564EUR$4,950USD£3,810GBP
- Report
- March 2026
- 99 Pages
Europe
From €3642EUR$3,950USD£3,040GBP
- Report
- March 2026
- 94 Pages
Asia Pacific
From €3642EUR$3,950USD£3,040GBP
- Report
- March 2026
- 79 Pages
Africa, Middle East
From €3181EUR$3,450USD£2,655GBP
- Report
- March 2026
- 90 Pages
North America
From €3181EUR$3,450USD£2,655GBP
- Report
- December 2024
- 305 Pages
Global
From €4564EUR$4,950USD£3,810GBP
- Report
- September 2024
- 152 Pages
Global
From €2074EUR$2,250USD£1,732GBP
- Report
- August 2025
- 150 Pages
Global
From €5485EUR$5,950USD£4,580GBP
From €3227EUR$3,500USD£2,694GBP
- Report
- December 2024
- 175 Pages
Global
From €4610EUR$5,000USD£3,849GBP
- Report
- January 2024
- 200 Pages
Global
From €3826EUR$4,150USD£3,194GBP
- Report
- April 2026
- 100 Pages
Spain
From €4379EUR$4,750USD£3,656GBP
- Report
- November 2025
- 150 Pages
Global
From €3457EUR$3,750USD£2,886GBP
- Report
- November 2025
- 150 Pages
Global
From €3457EUR$3,750USD£2,886GBP
- Report
- September 2022
- 120 Pages
Global
From €4149EUR$4,500USD£3,464GBP

The Structural Heart Device market is a subset of the Cardiovascular Devices market, which includes products used to diagnose and treat cardiovascular diseases. Structural Heart Devices are used to treat structural heart defects, such as atrial septal defects, patent foramen ovale, and mitral valve regurgitation. These devices are typically implanted in the heart and can include transcatheter aortic valve replacement (TAVR) devices, occluders, and annuloplasty rings.
Structural Heart Devices are used to improve patient outcomes and reduce the need for open-heart surgery. They are also used to reduce the risk of stroke and other complications associated with structural heart defects.
Some companies in the Structural Heart Device market include Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and St. Jude Medical. Show Less Read more